Hjem › Bløddelssarkom
Bløddelssarkom kliniske forsøg rekrutterer i USA
136 studier for Bløddelssarkom rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- Houston, TX32 studier
- New York City, NY19 studier
- Boston, MA18 studier
- St. Louis, MO14 studier
- Columbus, OH13 studier
- Los Angeles, CA13 studier
- Washington, DC12 studier
- Memphis, TN11 studier
- Philadelphia, PA10 studier
- Rochester, MN9 studier
- Nashville, TN9 studier
- Aurora, CO9 studier
- Queens, NY9 studier
- Atlanta, GA8 studier
- Durham, NC8 studier
- Grand Rapids, MI8 studier
- Santa Monica, CA7 studier
- Greenburgh, NY7 studier
- Baldwin Park, CA7 studier
- Chicago, IL7 studier
- Dallas, TX6 studier
- Mountain View, CA6 studier
- East Norwalk, CT6 studier
- Edison, NJ6 studier
- Staten Island, NY6 studier
- New Rochelle, NY6 studier
- Miami, FL6 studier
- Orange, CA6 studier
- San Francisco, CA6 studier
- Baltimore, MD6 studier
- Arlington, VA5 studier
- Birmingham, AL5 studier
- Cleveland, OH5 studier
- Pittsburgh, PA5 studier
- Cincinnati, OH5 studier
- Omaha, NE5 studier
- Jacksonville, FL4 studier
- San Antonio, TX4 studier
- Portland, OR4 studier
- Minneapolis, MN4 studier
Efter delstat
- Alabama6 studier
- Arizona6 studier
- Californien41 studier
- Colorado13 studier
- Connecticut4 studier
- District of Columbia7 studier
- Florida20 studier
- Georgia10 studier
- Illinois9 studier
- Indiana4 studier
- Iowa4 studier
- Kansas4 studier
- Kentucky3 studier
- Louisiana3 studier
- Maryland11 studier
- Massachusetts19 studier
- Michigan11 studier
- Minnesota13 studier
- Missouri15 studier
- Nebraska5 studier
- New Jersey8 studier
- New Mexico3 studier
- New York27 studier
- North Carolina13 studier
- Ohio23 studier
- Oregon4 studier
- Pennsylvania15 studier
- South Carolina3 studier
- Tennessee19 studier
- Texas37 studier
- Utah6 studier
- Virginia7 studier
- Wisconsin5 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
Distance-Based Exercise to Preserve Function and Prevent Disability
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07059884Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
4 Weeks · Alle køn · Opdateret 2. okt. 2026 · NCT01109394A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06942442Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 40 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT05334069A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06760819177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07189871Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06528769A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)
RekruttererFase 1/2
Alle aldre · Alle køn · Opdateret 1. okt. 2026 · NCT07602777Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT06498648FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma
RekruttererFase 1
Alder 3 til 39 · Alle køn · Opdateret 29. sep. 2026 · NCT06865664DESTINY-PANTUMOUR04
RekruttererObservationsstudie
Alder 18 til 130 · Alle køn · Opdateret 25. sep. 2026 · NCT07124000A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
RekruttererFase 1/2
Op til 25 år · Alle køn · Opdateret 25. sep. 2026 · NCT04094610A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT07229313Anti-GD2 ADC M3554 in Advanced Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT06641908A Study of CRD3874-SI in People With Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT06021626A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT07705334Biomarkers of Resiliency In Childhood Cancer Surgery
RekruttererObservationsstudie
Alder 3 til 25 · Alle køn · Opdateret 14. sep. 2026 · NCT06674811First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 11. sep. 2026 · NCT06797999Minibeam Radiation Therapy With Tungsten Slit Collimator for the Treatment of Recurrent or Metastatic Skin or Soft Tissue Tumors
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 11. sep. 2026 · NCT07062003Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
RekruttererFase 1
Alder 12 til 85 · Alle køn · Opdateret 8. sep. 2026 · NCT03715933Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT05732831Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT04577014First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT06644755Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT05711615GRID Therapy for Extremity Soft Tissue Sarcoma
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT06073067Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.